<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20250807066781N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-09-02</date_registration>
      <primary_sponsor>Islamic Azad University</primary_sponsor>
      <public_title>Comparison Of The Effectiveness Of Acceptance And Commitment Based Therapy With Schema Therapy On Depression, Health Anxiety, Adaptive Behavior And Psychological Hardiness In Patients With MS In Isfahan During The Covid-19 Epidemic.</public_title>
      <acronym></acronym>
      <scientific_title>Comparison Of The Effectiveness Of Acceptance And Commitment Based Therapy With Schema Therapy On Depression, Health Anxiety, Adaptive Behavior And Psychological Hardiness In Patients With MS In Isfahan During The Covid-19 Epidemic</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-09-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/85880</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Participants were randomly assigned to one of three groups—Acceptance and Commitment Therapy (ACT), Schema Therapy, or Waitlist Control—in a 1:1:1 ratio. To ensure balance and control for potential confounders, randomization was stratified by gender (male/female) and disease severity (EDSS &lt; 3.5 vs. ≥ 3.5). Within each stratum, variable block sizes (3, 6, and 9) were used to generate the allocation sequence.
The random sequence was generated by an independent researcher using computer-based random number generation with a fixed seed to allow reproducibility. Allocation concealment was achieved through the use of sequentially numbered, opaque, sealed envelopes (SNOSE), prepared for each stratum. After informed consent was obtained and baseline assessment (T1) was completed, the study coordinator opened the next envelope corresponding to the participant’s stratum to determine group assignment.
Outcome assessors at post-test (T2) and follow-up (T3) were blinded to participants’ group allocation to reduce bias. Data analysis followed the intention-to-treat principle, and participant flow through each stage of the study was documented using a CONSORT flow diagram, Blinding description: Due to the nature of psychological interventions, it was not possible to blind the participants to the type of treatment they received. However, to minimize bias, the study was conducted in a single-blind manner. Specifically, the outcome assessor who was responsible for data collection and analysis was blinded to the group allocation (Acceptance and Commitment Therapy vs. Schema Therapy). This procedure was implemented to enhance the accuracy of assessments and reduce the influence of researcher or participant expectations on the study outcomes.</study_design>
      <phase>N/A</phase>
      <hc_freetext>multiple sclerosis.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Acceptance and Commitment Therapy (ACT) group:Participants in this group will attend structured group sessions based on the ACT approach. The intervention focuses on enhancing acceptance of internal experiences, fostering present-moment awareness, clarifying personal values, and promoting commitment to adaptive behaviors. Intervention 2: Intervention group: Schema Therapy group:Participants in this group will attend group sessions based on Young’s schema therapy model. The intervention emphasizes identifying and modifying early maladaptive schemas and supporting patients in developing healthier emotional and behavioral patterns. Intervention 3: Control group: Participants in the control group received only their routine medical care throughout the study period and did not attend any of the psychological intervention sessions (Acceptance and Commitment Therapy or Schema Therapy). To address ethical considerations, access to similar therapeutic services was provided to these participants after the completion of the study.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
"Study results along with anonymized participant data"

When:
"From the time of publication until one year thereafter"

To whom:
"All researchers and clinical specialists"

Conditions:
"For clinical and research purposes"

Where to obtain:
Formal request to the corresponding author

How to obtain:
Initially discussed within the research team, and ultimately, the data will be shared upon approval

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Lotfollah Saberian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Zahedan</address>
        <city>Zahedan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9816743545</zip>
        <telephone>+98 913 591 1725</telephone>
        <email>lotfollahsaberian@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Lotfollah Saberian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Zahedan</address>
        <city>Zahedan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9816743545</zip>
        <telephone>+98 913 591 1725</telephone>
        <email>lotfollahsaberian@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Definitive diagnosis of MS based on medical records or neurologist criteria.
Age: 18 to 60 years.
Education level: Minimum literacy (to complete questionnaires).
Clinical status: Mild to moderate depression (based on standard questionnaire)
Written consent: Informed willingness to participate in research.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Having severe psychiatric disorders
Changing psychiatric or neurological medications during the study
Concurrent participation in other psychological treatments
Missing more than two therapy sessions
Unwillingness to continue cooperation or withdrawal of consent
Having a serious physical illness that prevents you from continuing your sessions</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G35</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Multiple sclerosis</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Acceptance and Commitment Therapy (ACT) group:Participants in this group will attend structured group sessions based on the ACT approach. The intervention focuses on enhancing acceptance of internal experiences, fostering present-moment awareness, clarifying personal values, and promoting commitment to adaptive behaviors.</i_keyword>
      <i_keyword>Intervention group: Schema Therapy group:Participants in this group will attend group sessions based on Young’s schema therapy model. The intervention emphasizes identifying and modifying early maladaptive schemas and supporting patients in developing healthier emotional and behavioral patterns.</i_keyword>
      <i_keyword>Control group: Participants in the control group received only their routine medical care throughout the study period and did not attend any of the psychological intervention sessions (Acceptance and Commitment Therapy or Schema Therapy). To address ethical considerations, access to similar therapeutic services was provided to these participants after the completion of the study.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Depression. Timepoint: pre and post interventions. Method of measurement: Beck depression questionaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Anxiety. Timepoint: pre and post intervention. Method of measurement: Beck Anxiety Inventory.</sec_outcome>
      <sec_outcome>Adaptive Behavior. Timepoint: pre and post intervention. Method of measurement: Lambert Adaptive Behavior Scale.</sec_outcome>
      <sec_outcome>Hardiness. Timepoint: pre and post intervention. Method of measurement: Long &amp; Goulet hardiness questionaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Islamic Azad University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-07-26</approval_date>
        <contact_name>Ethics Committee Islamic Azad University Zahedan Branch</contact_name>
        <contact_address>Islamic Azad University, Zahedan Branch Zahedan Sistan-va-Balouchestan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
